Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study

by Katsuhiro Ito, Yuki Kita, Akira Yokomizo, Jun Miki, Yuko Yoshio, Hiroaki Matsumoto, Takehiko Segawa, Takashi Karashima, Naotaka Nishiyama, Kazuto Imai, Shigetaka Suekane, Seiji Nagasawa, Shin Higashi, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi
Published 2023-02-01

The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions

by Fehr, Anthony R., Singh, Sasha A., Kerr, Catherine M., Mukai, Shin, Higashi, Hideyuki, Aikawa, Masanori
Published 2020